Navigation Links
Rare Drug-Resistant Bacteria Spotted in U.S. Hospital

By Steven Reinberg
HealthDay Reporter

THURSDAY, June 21 (HealthDay News) -- A rare type of deadly bacteria was found in two patients in a Rhode Island hospital in 2011, but swift treatment and infection control measures stopped any further spread, a new government report shows.

The bacterium -- called New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae -- is highly resistant to antibiotics and easily spread. It is rare in the United States, but more common in areas including India, Pakistan, Cambodia and other Asian countries.

"These people had the bacteria in their body, but fortunately it was not causing an infection anywhere," said lead researcher Dr. Leonard Mermel, medical director of the department of epidemiology and infection control at Rhode Island Hospital, in Providence.

The bacteria were isolated in one patient's urine sample and in another patient's fecal sample, but nowhere else in their body.

Infections with this strain of bacteria, however, can be deadly and there are few treatment options, Mermel said.

Where the bacteria is endemic, its growth is spurred on by several conditions, he said.

"In many parts of the developing world, you can just walk into a pharmacy and get antibiotics without a prescription, so there is widespread antibiotic use," Mermel said.

This ease of getting antibiotics coupled with poor sanitation promotes bacteria growth and creates a "perfect storm" for the development of resistant strains of bacteria, he said.

The report was published in this week's issue of Morbidity and Mortality Weekly Report, a publication of the U.S. Centers for Disease Control and Prevention.

The first patient was hospitalized in Rhode Island, after being hospitalized in her native Cambodia and treated with antibiotics. In the U.S. hospital, infection was discovered and she received a wide range of antibiotics. However, only partial infection control measures were taken. Eventually, the infection spread to another patient in the same ward.

At that time, stronger infection control measures were taken and no other patients were infected.

Dr. Marc Siegel, an infectious disease expert and associate professor of medicine at NYU Langone Medical Center in New York City, said that "this is not an epidemic, but it is eyebrow-raising. This bacteria is very problematic and highly resistant to antibiotics."

So far, this hasn't become epidemic, he said. "These are isolated cases," he said. "This is another resistant bacteria -- an ultra-resistant bacteria."

Siegel doesn't expect to see this bacteria become common in the United States.

"I don't think it's going to take hold here," he said. "I am concerned more about the importing of this bacteria. We are going to be seeing more cases."

The goal is to control the bacteria with infection precautions, including patient isolation, Siegel said.

This case drives home several points, he noted. "We need better sanitation in hospitals. We need to be vigilant in searching for these types of bacteria. We really could use more antibiotics. There have been almost no new antibiotics in the past decade."

It's the tip of the iceberg, Siegel said. "The iceberg is the developing of resistant bacteria, but this bacteria is not likely to spread in the near future, but it is of concern."

The overuse of antibiotics adds to the creation of these resistant strains, he added.

More information

For more on drug-resistant bacteria, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: Leonard A. Mermel, D.O., professor, medicine, Brown University, and medical director, department of epidemiology and infection control, Rhode Island Hospital, Providence, R.I.; Marc Siegel, M.D., associate professor, medicine, NYU Langone Medical Center, New York City; June 22, 2012, Morbidity and Mortality Weekly Report

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Medicine Might Fight Drug-Resistant TB, Study Says
2. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
3. Kinase test may yield big gains for drug-resistant cancers
4. Study Ties Kids Allergy Risks to Antibacterials, Preservatives
5. Killer stainless steel: New process gives icon of cleanliness antibacterial coating
6. Cedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut
7. Genomes show how Staph bacteria gain resistance to last-line drug
8. Zooming in on bacterial weapons in 3-D
9. Fish Pedicure a Recipe for Bacterial Infection, Researchers Warn
10. University of Minnesota startup to treat challenging bacterial infection
11. Children with juvenile arthritis have higher rates of bacterial infection
Post Your Comments:
Related Image:
Rare Drug-Resistant Bacteria Spotted in U.S. Hospital
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: